TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Chiron Pharmasynth AS
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
14,710
|
9,316
|
9,313 |
| Financial expenses |
124
|
134
|
130 |
| Earnings before taxes |
1,893
|
3,845
|
4,946 |
| Total assets |
28,458
|
25,541
|
21,661 |
| Current assets |
28,458
|
25,541
|
21,647 |
| Current liabilities |
10,880
|
9,769
|
7,222 |
| Equity capital |
17,578
|
15,772
|
14,439 |
| - share capital |
1,775
|
1,775
|
1,775 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
61.8%
|
61.8%
|
66.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
12.9%
|
41.3%
|
53.1% |
| Return on assets (ROA) |
7.1%
|
15.6%
|
23.4% |
| Current ratio |
261.6%
|
261.4%
|
299.7% |
| Return on equity (ROE) |
10.8%
|
24.4%
|
34.3% |
| Change turnover |
5,394
|
3
|
-1,665 |
| Change turnover % |
58%
|
0%
|
-15% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.